v" In order to test the safety and efficacy of Nucleolysin, a collagenase for intradiscal chemotherapy, laminectomies were performed on the L2-3 intervertebral discs of four groups of three young adult Cynomolgus monkeys. One primate from each group was injected with half the recommended human dose of Nucleolysin, chymopapain, or the same volume of sterile water. The remaining half of the human dose of each drug or equal volume of sterile water was equally divided and placed upon the right L-3 and L-4 nerve roots at their vertebral foramina. The fight L-4 nerve root was first compressed for 10 seconds with an aneurysm clip. These procedures were done to simulate inadvertent contact of enzyme with spinal nerves in patients undergoing chemonucleolysis. After 4 weeks of observation, the 12 primates were humanely killed and examined post mortem. The effects of both enzymes were limited to those tissues with which they came in direct contact. Complete digestion of the nucleus pulposus of all enzyme-injected intervertebral discs was observed. Variable portions of the anulus fibrosus (from 2.3% to 57.4%) were also dissolved. Direct contact of Nucleolysin with lumbar nerve roots caused minor perineural reaction and no more intraneural changes than seen in sterile water controls. Chymopapain induced mild to severe perineural skeletal muscle necrosis and fibrosis with perineural arterial lesions as well as a degenerative neuropathy which was more marked in the traumatized nerve. The results of this study suggest that Nucleolysin and chymopapain are approximately equally effective on intervertebral discs, and that Nucleolysin is less injurious to spinal nerve roots and perineural tissue at the doses used.
and identified by tattoo; their feces were tested for parasites. The monkeys were housed in individual cages, fed a standard diet of Purina Monkey Chow, and were observed every day. All the monkeys were judged to be healthy, no parasites were observed, and tuberculin tests were negative. The environmental qualities of an American Association for Accreditation of Laboratory Animal Care-accredited facility were monitored for the duration of the study, and remained within the limits specified in the facility's standard operating procedures. Current National Institutes of Health guidelines for the care and use of research animals and the requirements of the Food and Drug Administration's Good Laboratory Practices were followed. Twelve monkeys were assigned to treatment (Nucleolysin or chymopapain) or control (sterile water) groups by means of random card draw. One monkey from each of these treatment regimens was subjected to laminectomy on the same day following blood sampling for a complete blood count and radiography to document the width of the pretreatment lumbar disc spaces. The groups are summarized in Table 1 .
The primates were tranquilized with ketamine and given intravenous thiamylal sodium to a surgical plane of anesthesia. The aseptic surgical procedure involved removing the spinous processes and the vertebral arches from the right side of L-3 and L-4, and portions of L-2 and L-5. The spinal dura was exposed and the L2-3 intervertebral discs and nerve roots of L-3 and L-4 were visually identified. The L2-3 intervertebral disc was injected via a sterile tuberculin syringe with a No. 22 1 89 needle placed in the cranial-caudal center and about 1 to 2 mm to the fight of midline. The needle was inserted approximately 2.5 to 3.0 mm toward the center of the nucleus. The Nucleolysin and chymopapain had previously been thawed and diluted with appropriate diluent and allowed to stand according to explicit directions from the manufacturers. The total dose of either Nucleolysin or chympopapain administered to each monkey was equivalent to one recommended human therapeutic dose; one-half of the total dose was injected into the L2-3 disc and one-half was equally divided between the fight spinal nerves of L-3 and L-4. The L2-3 disc was injected with 300 ABC units (0.2 ml) Nucleolysin, 1500 U (0.2 ml) chymopapain, or (for controls) 0.2 ml sterile water. On three occasions the needle hub came free from the syringe because of the pressure necessary to inject the contents of the syringe into a normal disc. In one monkey, No. 83-10, only 225 U (0.15 ml) Nucleolysin was estimated to have been injected into the disc. In another case, No. 83-09, approximately 0.1 ml sterile water rather than 0.2 ml was injected into the disc. In a third monkey, No. 83-12, very little or no chymopapain was thought to have been injected on the first attempt; however, 0.3 ml chymopapain containing 1287 U was injected at a second attempt. Due to an inadvertent dilution error, monkey No. 83-12 received a slightly lower concentration of chymopapain in the L2-3 disc and a higher number of units were delivered to each nerve. It is estimated that the L2-3 disc of this animal received between 1287 and 1716 U and the fight L-3 and L-4 nerves each received 0.5 ml containing 1530 U chymopapain. In all other primates, the planned dose and dilution of enzyme was injected into the discs and spinal nerve foramina.
The fight L-3 nerve root was identified and onefourth of the usual human dose of enzyme, 150 U (0.25 ml) Nucleolysin, 750 U (0.25 ml) chymopapain, or 0.25 ml sterile water was introduced into the nerve foramen via a sterile soft No. 22 catheter on the end of a sterile tuberculin syringe. The right L-4 nerve was identified and a sterile aneurysm clip was placed just lateral to the dorsal root ganglion for 10 seconds. Immediately following physical compression of the nerve, 150 U (0.25 ml) Nucleolysin, 750 U (0.25 ml) chymopapain, or 0.25 ml sterile water was injected into the nerve foramen. A portion of the materials injected into the L-3 or L-4 nerve foramina was nearly always observed to flow back into the spinal canal. The surgical wounds were sutured closed about 1 hour after the initial incision. All of the monkeys were given a single intramuscular injection of a long-acting penicillin (1 ml FloCillin).
The animals were observed daily for the next 28 to 30 days. Recovery was generally rapid and uneventful. Just before sacrifice and necropsy a final radiograph was taken, blood was sampled for a complete blood count, and the monkeys were anesthetized with a barbiturate for cerebrospinal fluid collection from the foramen magnum. The monkeys were exsanguinated under deep anesthesia and autopsied immediately after.
At necropsy, the lumbar spinal column and major lumbar nerves were removed and fixed en bloc in 10% buffered formalin before a thorough necropsy was performed on the rest of the body. After fixation, the lumbar spinal column and cord with L1-7 nerve roots attached were dissected free of extraneous tissues and photographed. The lumbar intervertebral discs were measured and a transverse central section of each disc was removed and photographed. The L 1-5 vertebral bodies were sawed in half providing longitudinal sections with cranial and caudal portions of intervertebral discs attached. Cross sections of the spinal cord and vertebral bodies of L1-5; the right and left L1-7 nerve roots; the right and left lumbar obturator, flexor remoils, and femoralis nerves; samples of the skeletal muscle innervated by the latter three nerves; the L1-2 to L4-5 intervertebral discs; and other tissues including brain, liver, spleen, lung, heart, kidney, adrenal gland, and lumbar incision were decalcified as needed, processed for light microscopy, and stained with hematoxylin and eosin.
All histological slides were interpreted by a pathologist without knowledge of which drug treatment was given to individual animals. Nerve changes were graded by counting degenerating axons in 10 fields of longitudinal sections at x 400 magnification. Nerve root perineural tissue from L-3 to L-5 was examined for degree of inflammation, skeletal muscle necrosis and fibrosis, and arterial lesions. Inflammation was graded by averaging the estimated percent of surface area of nerve involved: Grade 0 = 0%; Grade 1 = 1%-20%; Grade 2 = 21%-40%; Grade 3 = 41%-60%; Grade 4 = 61%-80%; and Grade 5 = 81% or more. The approximate number of inflammatory cells per highpower field was classified as: Grade 0 = none; Grade 1 = 1-10; Grade 2 = 11-20; Grade 3 = 21-30; Grade 4 = 31-40; and Grade 5 = 41 or more. Skeletal muscle necrosis and fibrosis were graded by estimating the percent of skeletal muscle affected with either of these changes: Grade 0 = 0%; Grade 1 = 1%-10%; Grade 2 = 11%-20%; Grade 3 = 21%-30%; Grade 4 = 31%-40%; and Grade 5 = 41% or more. Arteriopathy was graded by averaging the estimated percent of arteries affected as: Grade 0 = 0%; Grade 1 = 1%-20%; Grade 2 = 21%-40%; Grade 3 = 41%-60%; Grade 4 = 61%-80%; and Grade 5 = 81% or more, and the relative degree of severity 0 to 5. Generally, more than one histological slide of each nerve root was graded. The mean degree of neural and perineural injury was calculated for each category.
Gross 2 x 2 color slides of all L2-3 intervertebral discs were projected onto grid paper and, with the aid of the histological slides, the portions of disc altered by enzyme were traced. From these scale drawings the areas of disc alteration were calculated and are reported in Table 2 .
Results

Physical Signs
Several monkeys developed serious effusions at the surgical site which were evacuated without incident. Slight gains or losses of body weight (up to 0.7 kg) occurred, but there were no significant weight changes among the groups. With few exceptions the monkeys returned to their presurgical level of cage activity within 12 to 24 hours. No monkey developed an obvious weakness or paralysis of limbs or muscle groups or any signs that could be directly related to injury of the lumbar nerves.
Radiographic Findings
The L2-3 intervertebral spaces were narrowed between 17% and 67% (mean 46%) of their previous cranial-caudal width in monkeys treated with Nucleolysin ( Fig. 1 ) and between 53% and 80% (mean 65%) in those given chymopapain. Three of the four control monkeys injected with sterile water showed no change, but one control monkey had an apparent 50% loss of intervertebral space (which was not confirmed at necropsy).
Clinical Pathological Findings
The results of complete blood counts just before drug injection or at necropsy 4 weeks later did not indicate any hematological abnormalities, except for a moderate anemia and leukopenia in one control monkey. Cerebrospinal fluid was collected from 10 monkeys, but samples from five of the monkeys were contaminated with blood. In the five samples free of gross blood (three from collagenase-and two from chymopapain-treated monkeys), the protein and cell counts were within normal limits.
Pathological Findings
Evaluation of L2-3 Disc. Complete digestion of the nucleus was observed in all primates injected with Nucleolysin or chymopapain ( able to either enzyme were found in the cartilagenous end plates of the L2-3 disc. The intervertebral discs from monkey No. 83-12 (injected with 1287 to 1716 U rather than the prescribed 1500 U chymopapain) and from primate No. 83-10 (which received 225 U instead of 300 U of Nucleolysin) had somewhat more anular digestion than average. Discs from both primates also had more than one needle puncture. (Fig. 4) . Neuronal degeneration of the same degree was not observed in the Nucleolysin-injected or control monkeys where degenerative changes were absent or only slight. The right L-3 nerve root bathed with Nucleolysin or chym o p a p a i n was not physically injured either. Chymopapain injected upon the right L-3 nerve root caused slight (two cases), moderate (one case), or severe (one case) neuropathy, whereas Nucleolysin-injected and control monkeys had only slight or no lesions (one case each). Similar lesions were found in the obturator, flexor femoris, and femoralis nerves. These nerves are supplied by the L3-5, L4-6, or L-7 nerve roots. They had approximately the same degree of injury as their nerve roots in most cases.
Perineuronal lesions consisting of inflammation, skeletal muscle injury., and an arteriopathy were present to various degrees about the right L-3, L-4, and sometimes L-5 nerve roots o f some primates (Tables 4 and  5 ). The inflammation was usually characterized by fo- 
m o s t entirely l i m i t e d to the c h y m o p a p a i n -t r e a t e d animals. P e r i n e u r o n a l arterial lesions w e r e c h a r a c t e r i z e d by m e d i a l t h i c k e n i n g w i t h l u m i n a l stenosis a n d adventitial fibrosis, e d e m a , or i n f l a m m a t i o n . T h e m e d i a l t h i c k e ning was a s s o c i a t e d w i t h a n e x t e n s i v e p r o l i f e r a t i o n o f s m o o t h -m u s c l e cells
, o f t e n w i t h a n a p p a r e n t i n c r e a s e d a m o u n t o f g r o u n d s u b s t a n c e a n d s o m e t i m e s w i t h focal necrosis, e d e m a , or f l b r i n o i d c h a n g e (Fig. 6) ; t h e r e were rare t h r o m b o s e s . T h e arterial c h a n g e s a p p e a r e d to be segmental and the affected arteries to have tortuous courses. Hemosiderin was often present about arterial lesions, suggesting previous hemorrhage. The arteriopathy was present in neural sections and sometimes in the epidural space of all chymopapain-treated monkeys. These peculiar arterial changes were absent in controls but were seen to a very minor degree in a few sections from three Nucleolysin-treated primates.
Perineuronal skeletal muscle lesions and arteriopathy were more marked in chymopapain-injected primates than in Nucleolysin-treated monkeys and were absent in controls ( Table 5 ). All of these lesions were severe and extensive in primate No. 83-12, which had been inadvertently given approximately twice the amount of chymopapain administered to other monkeys.
No lesions were recognized in the lumbar spinal cord other than occasional degenerative changes in one or more small subdural nerve roots. These minor changes were seen in most controls as well as in test monkeys. Epidural fibrosis, mononuclear inflammatory cell infiltrate, and hemosiderosis were observed from L-2 to L-5 in all monkeys.
No significant lesions were noted in the cerebrum, cerebellum, spleen, lung, heart, liver, kidney, or adrenal gland. Minor infiltrates of mononuclear cells were observed in occasional specimens of heart, lung, kidney, liver, and skeletal muscle. Skeletal muscle innervated by the L-3, L-4, and L-5 spinal nerves, including the fight and left rectus femoris, gracilis, and biceps femoris muscles, were found to have no obvious signs of neurogenic atrophy. All four primates that received chymopapain, but no other monkeys, had mild to moderate sarcosporidial infections of one or more of these muscles. In all four cases, the Sarcocystis parasites were encysted and there was no inflammation related to these cysts. The lumbar operative site was healing well in all monkeys and there were no signs of infections.
Discussion
The effects of Nucleolysin and chymopapain in this study appeared to be limited to those tissues that came in direct contact with either enzyme. No changes attributable to either enzyme were seen in clinical, hematological, or cerebrospinal fluid findings, nor were histopathological changes observed except in tissues in direct contact with either enzyme. Intradiscal or epidural administration of either enzyme in animals is not usually associated with systemic signs. Allergic reactions to chymopapain reported in man 5'5,~~ were not observed, nor have they been reported in animal studies by others.
The radiographic findings and the measurements of the L2-3 intervertebral discs at necropsy in this study clearly demonstrated a loss of cranial-caudal disc width in all primates injected with enzymes. In each animal, the injected L2-3 nucleus pulposus dissolved, allowing the disc to collapse. Dissolution of portions of the anulus fibrosus, especially near needle tracks, was also seen in all enzyme-treated primates. In one monkey given chymopapain, extensive destruction of anular collagen allowed the enzyme to come into contact with and dissolve the ventral (anterior) longitudinal ligament. Chymopapain principally lyses the chondromucoproteins of the disc nucleus. High doses may lyse anular collagen, 2a but clinical doses are not reported to affect the collagen of the anulus fibrosus. 11' 1a' 16' 24 Nucleolysin, being a collagenase, might be expected to dissolve portions of the anulus as well as the nucleus. 8,27' 29 The present study indicates that clinical doses of both chymopapain and Nucleolysin may digest portions of the anulus fibrosus.
No lesions attributable to either enzyme were observed in the cartilagenous end plates of injected discs or in underlying bone. Others have found that high doses of chymopapain 9 or collagenase 3~ will dissolve hyaline cartilage and bone, but clinical doses are generally considered safe in this regard. These findings appear to be contrary to a recent report by Artigas, et al., l of lesions in humans injected with collagenase. There are several important differences between their study and ours. A variable degree of preexisting disc lesions was presumably present in their study, whereas our primates had previously normal discs. Probably most important is that our study is based on detailed necropsy examination of whole specimens, whereas the Artigas study was limited to curetted tissues obtained at surgery. We observed foci of variable staining, mineralization, artifactual fissuring, and focal fibrosis in control as well as test monkeys. Such changes tend to make histological interpretation of these tissues difficult. It seems possible that some changes reported in fragments of curetted tissues may be artifactual rather than drug-related.
The study by Artigas, et aL,l suggests that the particular batch of collagenase used by them caused undue tissue damage. We have tested collagenase from the same lot number that they used by injecting 300 U into each of two discs and 600 U into the extradural space of each of two Cynomolgus monkeys. No abnormal clinical signs were observed during the following 14 days. Histopathological examination revealed no injury to cartilagenous end plates, vertebrae, ventral spinal ligaments, dura, or spinal cord. There was a mild inflammation of the spinal nerve roots and dorsal longitudinal ligament similar to that occurring in the control group injected with sterile water and the collagenaseand chymopapain-injected monkeys of the primary study.
Extrusion of disc material into the spinal canal with a foreign-body reaction to disc material was observed in three of our monkeys, including one from the control group. In no case was the amount of aberrant disc material sufficient to compress the spinal cord or nerve roots. To our knowledge, this lesion has not been reported by others following intradiscal injection. This extrusion of disc material may only occur in injected discs that were previously normal, the nucleus being under considerable pressure. Direct contact of collagenase or chymopapain on spinal nerve roots and surrounding tissue revealed striking differences. Both enzymes induced a perineural inflammation, probably of a transient nature. However, all primates given chymopapain developed perineural lesions, including skeletal muscle necrosis and fibrosis with distinctive arterial lesions. Muscle changes may be a result of nonspecific protease activity similar to that in papain used as a meat tenderizer. 27 Some monkeys treated in the same way with Nucleolysin developed slight lesions of a similar nature, but never to the same extent or degree. Control animals were negative for these changes.
It has been reported that epidural administration of chymopapain may ~9' 32 or may not 7'33 be associated with lesions. Similarly, severe 8 or minimal lesions 4 are reported with epidural collagenase and minimal lesions with subdural Nucleolysin. 29 The results of some animal experiments are difficult to evaluate. The relative dose, concentration, and purity of enzymes used in many studies before the late 1970's is doubtful. 2s The present study indicated no obvious dural or spinal cord injury due to either chymopapain or Nucleolysin injected into the epidural space.
A degenerative neuropathy was observed in the spinal nerve roots and associated lumbar nerves primarily of the chymopapain-treated monkeys. Nucleolysin-injected monkeys had about the same degree (negative to mild) of neuropathy as did control animals. The degenerative neuropathy was more severe in the traumatized (L-4) right nerve roots of monkeys treated with chymopapain, suggesting that previously injured nerves are more vulnerable to damage by chymopapain. The intraneural degenerative changes might heal with time, provided perineural lesions do not interfere. Peripheral nerve changes have been associated with chymopapain by some 3'14 '17-19 but not all workers, w'15'33 Nucleolysin has not to our knowledge been observed to be harmful to spinal nerve roots or peripheral nerves (B Rydevik, et aL, unpublished data, 1982) .
The arterial lesions that developed about nerves in direct contact with the enzymes in this study are of interest. The enzymes may lyse elements of the media and adventitia, weakening the vessel walls. In response, a proliferation of medial smooth-muscle cells and perivascular fibroblasts might develop. This could result in tissue ischemia as the enlarging media encroaches upon the lumen and the thickened adventitia inhibits tissue oxygenation.
Vascular lesions resulting in severe hemorrhage have been reported following intrathecal administration of both chymopapain and collagenase. 3'4'6-s'12'17 Proliferative and inflammatory or degenerative changes of small blood vessels that have come into direct contact with chymopapain have been observed in experimental animalsZ,3,17,19,32 and in man. 22 Thickening of meningeal vessels is also mentioned following intrathecal injection of Nucleolysin in dogs? Proliferative and occlusive changes of small arteries were observed in this study.
While minimal vascular lesions were present in some monkeys receiving Nucleolysin, markedly affected small arteries were observed in all primates given chymopapain.
Conclusions
Nucleolysin, chymopapain, or sterile water was injected into the intervertebral discs and spinal nerve root foramina of 12 healthy monkeys. Both Nucleolysin and chymopapain dissolved the nucleus pulposus and portions of the anulus fibrosus. Direct contact of chymopapain with lumbar nerve roots in the epidural space resulted in a degenerative neuropathy with significant perineural skeletal muscle necrosis and fibrosis, with associated perineural arterial lesions. The effects of Nucleolysin on lumbar nerve roots were similar to those seen in the sterile-water controls. These findings suggest that Nucleolysin is more target-specific and less dangerous to neural and muscular tissues than chymopapain at the doses used.
